Inspire Medical Systems (INSP) Projected to Post Earnings on Monday

Inspire Medical Systems (NYSE:INSP) is anticipated to issue its quarterly earnings data after the market closes on Monday, February 10th. Analysts expect the company to announce earnings of $0.74 per share and revenue of $239.76 million for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Monday, November 4th. The company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.06 by $0.54. The firm had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The business’s quarterly revenue was up 32.6% on a year-over-year basis. During the same period last year, the company earned ($0.29) earnings per share. On average, analysts expect Inspire Medical Systems to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Inspire Medical Systems Trading Down 0.4 %

NYSE:INSP opened at $193.90 on Monday. The stock’s 50-day moving average is $190.21 and its 200-day moving average is $188.66. The stock has a market cap of $5.81 billion, a P/E ratio of 181.22 and a beta of 1.32. Inspire Medical Systems has a 1-year low of $123.00 and a 1-year high of $257.40.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on INSP shares. Piper Sandler reaffirmed an “overweight” rating and set a $260.00 price target (up previously from $255.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Robert W. Baird raised their target price on Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 5th. Royal Bank of Canada reissued an “outperform” rating and issued a $260.00 price target on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Bank of America raised Inspire Medical Systems from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $220.00 to $255.00 in a research note on Wednesday, November 20th. Finally, Wells Fargo & Company increased their target price on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 5th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Inspire Medical Systems currently has a consensus rating of “Moderate Buy” and an average price target of $231.45.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.